门诊全髋关节置换术安全吗?
该研究回顾性分析2005—2014年美国外科医师学会国家手术质量改进计划数据库中63,844例全髋关节置换术患者,按住院时间将患者分为门诊组(住院0天,420例,0.66%)与住院组(住院1—5天,63,424例,99.34%),采用倾向性评分匹配后以多因素泊松回归比较术后30天内不良事件及再入院风险。匹配后门诊组除输血率低于住院组(3.69% vs 9.06%,P < .001)外,其余18项不良事件均无差异。作者认为在经适当选择的患者中可考虑门诊全髋关节置换术。
要点
- 门诊全髋关节置换术患者占0.66%(420/63,844),住院1—5天者占99.34%。
- 倾向性评分匹配后,门诊组输血率3.69% vs 住院组9.06%(P < .001),其余18项不良事件无差异。
- 作者认为,基于所评估的总体健康结局指标,经适当选择的患者可考虑门诊全髋关节置换术。
核心结论
- 采用倾向性评分匹配和多因素logistic回归校正潜在混杂因素后,门诊全髋关节置换术患者术后30天不良事件或再入院风险不高于住院手术患者。
- 基于所评估的总体健康结局指标,该数据支持在经适当选择的患者中可考虑门诊全髋关节置换术。
研究设计与样本
- 回顾性分析前瞻性收集的2005—2014年美国外科医师学会国家手术质量改进计划数据库数据。
- 接受全髋关节置换术的患者按出院日分为门诊组(住院时间0天)和住院组(住院时间1—5天),住院时间超过5天者被排除。
- 共识别63,844例全髋关节置换术患者,其中门诊420例(0.66%),住院1—5天63,424例(99.34%)。
- 采用倾向性评分匹配处理研究组间基线非随机分配,匹配后人群以多因素泊松回归比较术后初始30天内不良事件(包括再入院)的相对风险。
主要发现
- 门诊患者倾向于更年轻、男性、合并症更少。
- 倾向性评分匹配后,门诊组在评估的18项不良事件中除输血外均无差异。
- 门诊组输血率3.69% vs 住院1—5天组9.06%(P < .001),门诊组低于住院组。
临床怎么用
- 作者认为,基于所评估的总体健康结局指标,该数据支持在经适当选择的患者中可考虑门诊全髋关节置换术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Safety data for outpatient total hip arthroplasty (THA) remains scarce. METHODS: The present study retrospectively reviews prospectively collected data from the 2005-2014 American College of Surgeons National Surgical Quality Improvement Program Database. Patients who underwent THA were categorized by day of hospital discharge to be outpatient (length of stay [LOS] 0 days) or inpatient (LOS 1-5 days). Those with extended LOS beyond 5 days were excluded. To account for baseline nonrandom assignment between the study groups, propensity score matching was used. The propensity matched populations were then compared with multivariate Poisson regression to compare the relative risks of adverse events during the initial 30 postoperative days including readmission. RESULTS: A total of 63,844 THA patients were identified. Of these, 420 (0.66%) were performed as outpatients and 63,424 (99.34%) had LOS 1-5 days. Outpatients tended to be younger, male, and to have fewer comorbidities. After propensity score matching, outpatients had no difference in any of 18 adverse events evaluated other than blood transfusion, which was less for outpatients than those with a LOS of 1-5 days (3.69% vs 9.06%, P < .001). CONCLUSION: After adjusting for potential confounders using propensity score matching and multivariate logistic regression, patients undergoing outpatient THA were not at greater risk of 30 days adverse events or readmission than those that were performed as inpatient procedures. Based on the general health outcome measures assessed, this data supports the notion that outpatient THA can appropriately be considered in appropriately selected patients.
引用
- Nelson SJ, Webb ML, Lukasiewicz AM, et al. Is Outpatient Total Hip Arthroplasty Safe? J Arthroplasty. 2016. PMID: 28065622. doi:10.1016/j.arth.2016.11.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。